FDA Changes Prescribing Instructions for Controversial Alzheimer’s Drug

July 8, 2021 by Dan McCue
FDA Changes Prescribing Instructions for Controversial Alzheimer’s Drug

U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug.

The announcement came through Biogen Inc., the maker of Aduhelm, which stated the update is intended to “clarify” the patients studied in the company trials that led to approval.

The new labeling approved by the FDA state’s the drug is appropriate for patients exhibiting signs of mild cognitive impairment or mild dementia.

When the drug was first approved a top FDA official told reporters the drug was “relevant to all stages of Alzheimer’s disease.”

But that led to weeks of blowback and consternation. The FDA then approached the company about narrowing the label and approved the language to address confusion among physicians and patients.

The FDA now warns that there is “no safety or effectiveness data on initiating treatment at earlier or later stages of the disease than were studied.” 

Biogen’s head of research and development, Dr. Alfred Sandrock, Jr. said the new labeling is based “on our ongoing conversations with prescribing physicians, FDA and patient advocates. 

“We submitted this label update with the goal to further clarify the patient population that was studied across the three Aduhelm clinical trials that supported approval,” he added.

Despite the update, the FDA added that “some patients may benefit from ongoing treatment” if they develop more advanced Alzheimer’s.

The label change comes one month after FDA’s approval of the drug, which quickly sparked controversy over its $56,000-a-year price-tag and questionable benefits. 

Three of FDA’s outside advisers resigned over the decision with one prominent Harvard expert calling it the “worst drug approval decision in recent U.S. history.”

A+
a-
  • Aduhelm
  • Biogen
  • FDA
  • In The News

    Health

    Voting

    Prescription Drugs

    Biden and Harris Team Up for Health Care Event in North Carolina

    WASHINGTON (AP) — President Joe Biden and Vice President Kamala Harris will promote their health care agenda on Tuesday in... Read More

    WASHINGTON (AP) — President Joe Biden and Vice President Kamala Harris will promote their health care agenda on Tuesday in North Carolina, a battleground state that Democrats hope to flip in their favor after falling short to Donald Trump in the last two presidential elections. Fourteen... Read More

    March 13, 2024
    by Dan McCue
    FDA Believed Poised to Approve First Med for a Serious Liver Disease

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious... Read More

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious liver disease known as MASH later this week.  Metabolic dysfunction-associated steatohepatitis -- formerly known as nonalcoholic steatohepatitis — is often associated with obesity. In patients who... Read More

    March 6, 2024
    by Dan McCue
    Health Care, Drug Prices to Be Cornerstone of State of the Union

    WASHINGTON — President Joe Biden’s plans to do more to lower prescription drug prices and ensure the nation’s health care... Read More

    WASHINGTON — President Joe Biden’s plans to do more to lower prescription drug prices and ensure the nation’s health care system works better for more Americans will be the centerpiece of his State of the Union address, the White House revealed Wednesday. In a conference call... Read More

    March 4, 2024
    by Dan McCue
    Judge Rules Against Drugmaker in Price Negotiation Lawsuit

    WILMINGTON, Del. — A federal judge in Delaware ruled against the pharmaceutical and biotech company AstraZeneca last Friday in a... Read More

    WILMINGTON, Del. — A federal judge in Delaware ruled against the pharmaceutical and biotech company AstraZeneca last Friday in a case challenging the constitutionality of Medicare’s new drug negotiation program. The case is one of several filed by the pharmaceutical industry and its allies and the... Read More

    March 1, 2024
    by Dan McCue
    CVS, Walgreens to Begin Selling Abortion Pills Later This Month

    WASHINGTON — The nation’s two largest pharmacy chains will start dispensing the abortion pill mifepristone in select states later this... Read More

    WASHINGTON — The nation’s two largest pharmacy chains will start dispensing the abortion pill mifepristone in select states later this month, just weeks before the Supreme Court is set to hear a case that could lead to its removal from the market. The decision by both... Read More

    February 22, 2024
    by Dan McCue
    House Democrats Launch Inquiry Into Nationwide Drug Shortages

    WASHINGTON — Democrats on the House Committee on Oversight and Accountability are pressing some of the nation's largest drug manufacturers... Read More

    WASHINGTON — Democrats on the House Committee on Oversight and Accountability are pressing some of the nation's largest drug manufacturers for answers on why there are still intermittent and repeated shortages of cancer meds and other drugs. Led by Rep. Jamie Raskin, D-Md., the ranking member... Read More

    News From The Well
    scroll top